Seeking Alpha

Shares of Medivation (MDVN) fall 6% premarket. Likely weighing on shares is Johnson &...

Shares of Medivation (MDVN) fall 6% premarket. Likely weighing on shares is Johnson & Johnson's acquisition of Aragon, whose prostate cancer drug ARN-509 was the subject of a lawsuit MDVN filed claiming rights to the compound.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs